2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …
N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes mellitus: a systematic review and meta-analysis
M De Vries, J Westerink… - The Journal of …, 2020 - academic.oup.com
Context Nonalcoholic fatty liver disease (NAFLD) prevalence is high, especially in patients
with obesity and type 2 diabetes, and is expected to rise steeply in the coming decades …
with obesity and type 2 diabetes, and is expected to rise steeply in the coming decades …
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
ME Rinella, BA Neuschwander-Tetri, MS Siddiqui… - Hepatology, 2023 - journals.lww.com
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AI, artificial
intelligence; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC …
intelligence; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC …
[HTML][HTML] Magnesium deficiency and cardiometabolic disease
R Fritzen, A Davies, M Veenhuizen, M Campbell… - Nutrients, 2023 - mdpi.com
Magnesium (Mg2+) has many physiological functions within the body. These include
important roles in maintaining cardiovascular functioning, where it contributes to the …
important roles in maintaining cardiovascular functioning, where it contributes to the …
Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: beyond glycated haemoglobin
R Helliwell, H Warnes, N Kietsiriroje… - Diabetic …, 2021 - Wiley Online Library
Aims To understand the relationship between insulin resistance (IR), assessed as estimated
glucose disposal rate (eGDR), and microvascular/macrovascular complications in people …
glucose disposal rate (eGDR), and microvascular/macrovascular complications in people …
[HTML][HTML] Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational study
W Linn, M Persson, B Rathsman, J Ludvigsson… - Cardiovascular …, 2023 - Springer
Aims The aim of this study was to investigate the association between estimated glucose
disposal rate (eGDR), a proxy for insulin resistance, and retinopathy or kidney disease, ie …
disposal rate (eGDR), a proxy for insulin resistance, and retinopathy or kidney disease, ie …
[HTML][HTML] Double diabetes—when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition
W Bielka, A Przezak, P Molęda… - Cardiovascular …, 2024 - Springer
Currently, the differentiation between type 1 diabetes (T1D) and type 2 diabetes (T2D) is not
straightforward, and the features of both types of diabetes coexist in one subject. This …
straightforward, and the features of both types of diabetes coexist in one subject. This …
[HTML][HTML] The association between overweight/obesity and double diabetes in adults with type 1 diabetes; a cross-sectional study
NWP Cantley, K Lonnen, I Kyrou, AA Tahrani… - BMC endocrine …, 2021 - Springer
Abstract Background Double Diabetes (DD), type 1 diabetes (T1DM)+ insulin resistance
(IR), is associated with increased risk of micro/macro-vascular complications and mortality …
(IR), is associated with increased risk of micro/macro-vascular complications and mortality …
Obesity and diabetic complications: a study from the nationwide diabetes report of the National Program for Prevention and Control of Diabetes (NPPCD-2021) …
F Moosaie, F Ghaemi, JI Mechanick, M Shadnoush… - Primary Care …, 2022 - Elsevier
Background Obesity plays a major role in the pathogenesis and development of macro-and
microvascular complications of type 2 diabetes (T2D) and type 1 diabetes (T1D). We aimed …
microvascular complications of type 2 diabetes (T2D) and type 1 diabetes (T1D). We aimed …
[HTML][HTML] Theasinensin A attenuated diabetic development by restoring glucose homeostasis, improving hepatic steatosis and modulating gut microbiota in high-fat-diet …
W Xu, Y Huang, W Zhou, Y Peng, X Kan… - Food Science and …, 2023 - Elsevier
Theasinensin A (TSA), a dimer of epigallocatechin gallate, has been preliminarily
demonstrated to have hypoglycemia and anti-inflammatory effects. However, little …
demonstrated to have hypoglycemia and anti-inflammatory effects. However, little …